Gardasil poses unnecessary risk of injury, death
November 2nd, 2008 by Kurt Niland
Dr. Diane Harper, the lead researcher in human papilloma virus (HPV) vaccine development, astonished her peers at the 4th International Public Conference on Vaccination last month when she spoke out against Merck’s Gardasil vaccination, rather than promote it as she was expected to do.
Dr. Harper, who serves as director of the Gynecologic Cancer Prevention Research Group at the University of Missouri, opened her presentation with an overview of HPV that didn’t exactly inspire confidence in the usefulness of the vaccine. The rate of cervical cancer, which is caused by HPV, she said, was already so low and so treatable in the U.S. that vaccinations would effectively do nothing to lower it.
Preventative measures and current treatments are already lowering the occurrence of HPV and cervical cancer faster than the vaccination could, Dr. Harper said, explaining that the cervical cancer rate will be reduced more than 91 percent in 60 years time without the vaccination.
But Dr. Harper’s explanation of Gardasil’s uselessness wasn’t as eye-opening or alarming as some of her other allegations. In light of Merck’s aggressive lobbying efforts to make Gardasil mandatory for school-age girls, it’s especially upsetting that Dr. Harper told her audience that the manufacturer never conducted any safety or efficacy trials in girls under 15 years old and that vaccinating young girls en masse amounted to “a great big public health experiment.”
That Merck would develop an unnecessary vaccine, force it on the public, and then take a “wait and see” approach to gauge its safety is unconscionable. One can only imagine the dollar signs Merck’s leadership saw as they looked upon a whole nation of girls unvaccinated against HPV.
Any corporation like Merck that holds the health of millions in its grasp wields a staggering amount of power. It should upset the millions of American moms and dads that Merck regards their young daughters as guinea pigs – the unwitting subjects of a vaccination experiment destined to add billions more dollars to its corporate coffers. How many health professionals and medical organizations have been swayed by Merck’s political lobbying, financial rewards, misinformation and other abuses of that power?
A lot, I suspect. My younger sister has four daughters who range in age from 16 years to 2. When she takes her two oldest daughters for check ups, the pediatrician typically tells her she should have them vaccinated against HPV with injections of Gardasil. Most recently, the doctor pressured my sister to have her 11-year-old vaccinated.
Fortunately, my sister decided to research the vaccine before agreeing to the shots and has said no.
“It’s such a shame that companies are allowed to prey on kids like that,” my sister told me, adding that she is glad she has repeatedly told the doctors “no” to the shots in light of the news that they are dangerous and potentially deadly to some girls.
Since Gardasil first appeared in 2006, 15,037 inoculated girls have reported adverse side effects to the Vaccine Adverse Event Reporting System (VAERS). Reactions that have been officially reported include brain inflammation, seizures, blood clots, paralysis, lupus, Guilliane Barre Syndrome, and several others. 44 deaths attributed to the vaccine have been reported to the Centers for Disease Control and Prevention (CDC).
If what Dr. Harper says is true, then all 44 of those deaths were completely unnecessary. That even more women and girls will be sacrificed for Merck’s bottom line as Gardasil shots are unnecessarily doled out is nothing less than criminal.